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Abstract
Background: The purpose of this study was to determine disease associations with dyschromonychia (DCO) in an out-
and inpatient population attending Kalafong Hospital.
Methods: This prospective and observational study included in- and out-patients attending the Immunology Clinic at
Kalafong Hospital, Pretoria, Gauteng. The study was divided into three phases, the first of which was to evaluate the
kappa values and prevalence of DCO. The second was to determine the disease associations of in-patients, and the
third phase consisted of nail evaluation in an out-patient HIV-positive population.
Results: The kappa value was 0.72, as obtained by three investigators. DCO was found to have a 66% sensitivity, 92%
specificity, 66% positive predictive value, 92% negative predictive value, a positive likelihood ratio of 8.2 and a negative
likelihood ratio of 0.4 for HIV (inpatients). Patients with DCO were found to have a significantly higher rate of infections
(predominantly involving the lung), significantly lower lymphocyte counts and CD4 cell counts, and significantly lower
CD4:CD8 ratios and albumin levels (p = 0.0001). The best discriminatory CD4 for DCO was 216.6 x 10 6/l (sensitivity =
89%; specificity = 63%), while a CD4 value of 134.3 x 10 6/l  yielded a sensitivity of 75% and a specificity of 73%.
Conclusions: This study demonstrates a close association between HIV and DCO, especially in the case of lower CD4
cell counts. The absence of DCO is a poor predictor for the presence of HIV, although its presence has a high sensitivity
for HIV seropositivity. The clinical finding of DCO  is a simple, quick and efficient sign for the evaluation of the immune
status of our population with reasonable sensitivity and specificity for low CD4 cell counts.
       (SA Fam Pract 2005;47(8): 54-59)
Introduction
Dyschromonychia (DCO) is a change
in nail and nail-bed colour other than
normal and is a term generally applied
to patients with increased nail
pigmentation. It is our and other
clinicians’ experience that more
patients are noted with DCO,
especially in association with
advanced human immunodeficiency
virus infection (HIV). In 1987, Furth
and Kazakis were the first to report
two patients with a particular pattern
of DCO.1 Both patients were HIV
positive, African-American, and were
on azidothymidine (AZT) therapy. The
first of the two patients was referred
to an emergency department for
“cyanosis”; however, arterial blood
gas pressures were normal. The
doctors concluded that the DCO was
the result of AZT therapy. An additional
five black patients with HIV/AIDS and
DCO, for which there appears to be
no cause other than HIV, have been
reported in the literature.2-5
Besides the aforementioned
reports (with the exception of one
article that will be discussed later),
there are no other known reports of
DCO in HIV patients. We found this to
be peculiar in the light of the frequency
with which it is observed in clinical
practice. The aim of this study was to
determine the disease associations in
an out- and in-patient population
attending a state hospital.
Materials and methods
This was a prospective observational
study including an in- and out-patient
population to evaluate DCO in a
predominantly HIV-positive setting.
Following ethical clearance from the
University of Pretoria, patients were
included in the study after their consent
had been obtained. The out-patient
population consisted of patients
attending the Immunology Clinic at
Kalafong Hospital, Pretoria, Gauteng.
The in-patients were ward patients of
the same hospital. The term DCO was
used to denote the presence of nail
and/or nail-bed dyschromia. This study
makes no distinction between the latter
two findings and therefore both
conditions are included under DCO.
The study hypothesis was that
DCO is a predictor of advanced HIV
disease. Dyschromonychia was
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clinically defined as the total absence
of the nail lunula (all nails), with the
presence of a bluish-grey discoloration
of the nail or nail bed, extending from
the base of the nail (on any nail). All
nails, on the fingers and toes, were
evaluated. Patients were included if
HIV serology and a CD4 cell count
had been performed. The only
exclusion criterion was the inability to
evaluate the patient’s nails (nail polish
or nail dystrophy).
The study was divided into three
phases. The first was the evaluation,
by three doctors, of the kappa values
and prevalence of DCO in an out-
patient population. Two doctors were
specialist physicians and the third was
an HIV specialist. One hundred
consecutive clinic patients were
evaluated.
The second phase of the study
determined in which patients DCO
was present. The study population
consisted of 183 in-patients admitted
to medical wards at Kalafong Hospital.
Following patient consent, their nails
were examined for the presence of
DCO by one doctor. Correlations were
made for disease associations.
Previous and present diseases,
medication and biochemical findings
were documented on a patient
information sheet.
The third phase of the study
consisted of nail evaluation in an out-
patient HIV-positive population by
doctors who had not been taught to
evaluate DCO. A total of 137
outpatients were randomly selected
and evaluated by seven different
doctors. Pictures of normal and DCO
nails were left on each doctor’s table
for comparison. The doctors were
asked to determine the presence or
absence of DCO. The patient history,
the results of a clinical examination,
med ica t i on  use  and  b lood
investigations (urea, creatinine,
calcium, l iver funct ion tests,
cholesterol, C-reactive protein, full
blood count, erythrocyte sedimentation
rate, CD4, CD8, cell ratios and syphilis
serology) were noted on a data
collection sheet.
The data were computed and
statistically analysed using Statistica
6.0. The probability value was set at
0.05, and the Student’s t-test was used
to determine significant biochemical,
haematological or clinical differences
between patients with and without
DCO. The Bonferoni equation was
applied where indicated. The ChiX2
Table I: Demographics of the study population
Observation
Total number


























































36 black; 2 white; 2 Asian
All positive
Figure 1:  Examples of dyschromonychia (predominantly nail bed and compressible).
Note the loss of lunula with the blue-grey hue extending from the base of the nail,
generally involving less than half of the nail
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test was used to determine the
significant difference between disease
prof i les and HIV prevalence.
Results
Patient demographics are shown in
Table I and examples of DCO are
shown in Figures 1 and 2. The kappa
value was determined to be 0.72 for
the DCO evaluation. The prevalence
of DCO in patients in the Immunology
Clinic was 19.00% and in the ward
patients it was 51.61%. The nails
involved most commonly were those
of the thumb and the ring finger (Figure
3). In 7.25% of cases, all fingernails
were equally affected. The toenails
were more difficult to evaluate, with
only 33.59% found to be positive,
together with concomitant fingernail
DCO. There were no patients with
exclusive toenail DCO. Most patients
were unaware of the nail changes
(80%), and only 20% of the patients
had observed a change in nail colour.
The mean duration of DCO was 4.7 ±
5.7 months (min = 1 month, max = 24
months) (Figure 4).
Inpat ien ts  w i th  DCO had
significantly higher rates of infections,
predominantly involving the lung (Table
II), as well as a significantly higher
prevalence of HIV infection (97.00%
vs. 59.04%), significantly lower
lymphocyte, CD4, and albumin levels,
as well as a significantly lower
CD4:CD8 ratio (p 0.0001). Of all the
biochemical and haematological
variables examined (see Materials and
Methods), only the aforementioned
were found to be significantly different
(Bonferoni equation: p < 0.0019).
Previous medication used by the
patients with and without DCO did not
di ffer,  wi th the except ion of
trimethroprim, which was used as a
prophylaxis in known HIV-positive
patients.
Dyschromonychia was found to
have 66% sensitivity, 92% specificity,
66% positive predictive value, 92%
negative predictive value (prevalence
Figure 2:  Examples of dyschromonychia (non-compressible). Generally involves
more than half the nail.
Figure 3:  The nail in which dyschromonychia was most prominent (n = 128 patients)
Figure 4: Duration for which dyschromonychia was noted by patients (n = 22 patients)
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of in-patients tested for HIV in medical
wards is 80-90%; unpublished
findings, PF Levay), a positive
likelihood ratio of 8.2 and a negative
likelihood ratio of 0.4 in the HIV in-
patient population. The association
with HIV was further supported by the
various nail patterns and progressive
decline in CD4 cell counts (see Table
I I I  and Figure 5) .  The best
discriminatory CD4 for DCO was 216.6
x 106/l (sensitivity = 89%; specificity
= 63%), while a CD4 value of 134.3 x
106/l yielded a sensitivity of 75% and
a specificity of 73%. Eliminating
patients with leukonychia increased
the specificity from 63% to 68%.
Three patients had DCO but were
HIV-negative on blood serology. The
first patient was a 53-year-old male
with squamous cell cancer of the lung
Figure 5: Association with various nail presentations and CD4 cell counts




















































































































[ChiX2 test used for disease group, organ involved and HIV status analysis, Student’s t-test used for blood analysis determinations, NS = non significant p > 0.0019]
[0.0001 for all variables between group 1 and group 4, except CD8 cell count]
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who had received chemotherapy
(adriamycin-containing regime), which
is known to cause DCO. The second
was a 33-year-old female patient who
had chronic lung disease due to
previous pulmonary tuberculosis,
complicated by bronchiectasis,
clubbing and superimposed chronic
pneumonia. The third patient was a
27-year-old male with chronic lung
disease complicated by empyema.
All the outpatients examined were
HIV positive. Unlike the inpatients, no
significantly higher incidence of
infective diseases was found in those
with or without DCO. However,
previous pulmonary disease  was
found to be significantly higher in
patients with DCO. The use of
trimethroprim was substantially higher
in patients with DCO, although this is
most likely due to their lower CD4 cell
c o u n t s .  B i o c h e m i c a l  a n d
haematological differences were
almost the same as for in-patients:
lower CD4 cell counts, CD4:CD8 ratios
and albumin levels (Table IV, Figure
6). The presence of DCO was 74%
sensitive and 78% specific for a CD4
cell count of 130.
Discussion
In the present HIV/AIDS epidemic,
clinicians have generally observed an
increased occurrence of DCO. DCO
is generally assumed to be a sign of
advanced HIV/AIDS, despite there
being little substantiated evidence.
This is the first study to investigate
the sensitivity and specificity of DCO
and associated diseases. Our findings
indicate an association with HIV
infection. The only other study to
investigate DCO examined 75 patients
attending the Kilimanjaro Christian
Medical Centre.6 All the patients in this
study were HIV positive, indicating a
specificity of 100% in the population
studied. In the present study, the
specificity was found to be 66%,
although it is related to the stage of
HIV. Sensitivity was not examined in










  Other than lung
Medication history
  Positive trimethroprim use
  Negative trimethroprim use
Blood analyses
  Lymphocyte count (x106/l)
  CD4 count (x106/l)
  CD4 percentage
  CD8 count (x106/l)
  CD8 percentage
  CD4:CD8 ratio
  Albumin (g/l)













































[ChiX2 test used for disease group, organ involved and HIV status analysis, Student’s t-test used for blood analysis determinations, NS = non significant p > 0.0019]
Figure 5: Association with various nail presentations and CD4 cell counts
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the aforementioned study, as patients
without nail dyschromia were not
tested for HIV. The current study found
a clear relationship between the stage
of HIV based on CD4 cell counts and
the presence of DCO. In both the in-
and out-patient setting, the presence
of DCO was approximately 75%
sensitive and specific for CD4 cell
counts below approximately 140 x
106/l.
Leppard describes DCO as a
diffuse, bluish discoloration, rather
than linear, pigmented bands, which
begins in the lunulae and gradually
spreads distally.6 The findings of this
study correspond with those of
previous authors. There appears to
be a progression in nail findings,
ranging from normal nails, dyschromia
of the nail bed in the presence of a
lunula, alternatively disappearance of
the lunula without dyschromia, then
loss of the lunula with dyschromia,
followed by or associated with nail
dyschromia, which has been noted to
be  a  p redomina te l y  b rown
discoloration, often extending the full
length of the nail. The brown
discoloration is non-compressible. As
in previous reports, the DCO is a blue-
grey discoloration, most prominent on
the thumbnail, extending from the nail
base towards the nail edge, rarely
longer than half the nail, and it
disappears on compression. Toenails
have been reported to be affected
later than fingernails, possible due to
their slower growth rate.5 This study
found toenail evaluation to be far
inferior to fingernail evaluation,
possible due to the population
examined, the members of whom are
generally poor and who practise poor
hygiene. It is therefore the authors’
opinion that toenail evaluation for
dyschromia is ineffective and should
be abandoned in favour of fingernail
evaluation.
There are no known reports of DCO
in white patients, although we have
observed these changes in three white
males (none on antiretroviral therapy).
One of these patients is presently
following-up at the Immunology Clinic,
and two have died (one after a fourth
episode of cyptococcus meningitis,
and the other from tuberculous
meningitis and psoriasis). All these
patients’ CD4 counts were lower than
100 x 106/l.
The mechanism responsible for
the occurrence of DCO is unknown.
This study clearly demonstrates an
association with advanced HIV,
although it would be rash to consider
this a sign peculiar to this disease.
HIV is more likely to be the precipitant,
leading to immunosuppression and
increased infections. The three patients
with DCO in the absence of HIV
infection noted in this study had
chronic lung disease. Since the
initiation of this study, another HIV-
negative patient has been noted with
DCO, with a necrotising pneumonia,
finger clubbing, destruction of his left
lung, and with a large abscess in the
upper lobe of the right lung. It would
appear that chronic forms of lung
infections are a more likely etiology
for DCO than HIV infection itself. The
argument of cyanosis as an etiological
factor does not stand ground. Most of
our patients demonstrated no central
cyanosis, and those who did, retained
their DCO when given supplemental
oxygen (PO2 returned to normal on
blood gas).
Study limitations include possible
bias due to the high prevalence of HIV
in the population studied. The
prevalence differed between out- and
in-patients, although the sensitivities
and specificities for CD4 levels did
not, indicating that sensitivities and
specificities for the CD4 cell count
may be retained in communities with
lower HIV prevalence. The population
studied was predominately black, with
only three white patients included. This
reflects the population served by the
hospital. Additional causes of DCO
(such as silver intoxication) were not
excluded, although these causes were
unlikely in the light of the prevalence
of DCO in our population.
In  conc lus ion,  th is  s tudy
demonstrates a close association
between HIV and DCO, especially in
patients with lower CD4 cell counts.
The absence of DCO is a poor
predictor for the presence of HIV,
although its presence has a high
sensitivity. The identification of DCO
is a simple, quick, and efficient method
for evaluating the immune status of
our population with reasonable
sensitivity and specificity for a CD4
value of 140 and below. DCO is most
likely a feature of chronic infection,
possibly chronic lung infections. The
pathophysiology of this clinical sign
warrants fur ther investigation.
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